Canada gives full approval to J&J's single-shot COVID-19 vaccine

1 minute read

Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

Register now for FREE unlimited access to Reuters.com

Nov 24 (Reuters) - Johnson & Johnson (JNJ.N) said on Wednesday Canada gave full approval to its single-shot COVID-19 vaccine for people aged 18 years and older, making it the first full approval for the vaccine globally.

The vaccine was previously authorised by the country under an interim order. (https://refini.tv/30Zd5TR)

Canada, which is reporting 2,563 infections on average each day and has administered at least 60,101,058 doses of COVID-19 vaccines so far, gave full approval to Moderna Inc (MRNA.O) and Pfizer Inc's (PFE.N) coronavirus vaccines in September.

The country authorised the use of Pfizer's COVID-19 vaccine for children aged 5 to 11 and a booster dose for people aged 18 years and older this month. read more

J&J's coronavirus vaccine has been authorised for emergency use in many countries, including the United States.

Register now for FREE unlimited access to Reuters.com
Reporting by Dania Nadeem in Bengaluru; Editing by Shounak Dasgupta

Our Standards: The Thomson Reuters Trust Principles.